MaxCyte’s cutting-edge cell transfection technology is now available to researchers and biotech innovators across India. MaxCyte, a global leader in non-viral, high-performance transfection systems, enables scalable, reliable, and efficient delivery of molecules into a wide range of cell types – from hard-to-transfect primary cells to complex cell lines.
Accelerate your journey from discovery to commercialization in cell therapy, gene editing, and biomanufacturing with MaxCyte’s flow electroporation platform.
